drugset / Trial / NCT06359834

Comparison of Remimazolam and Propofol Effect on Oxygen Reserve During Endoscopic Retrograde Cholangiopancreatography

NCT06359834

Completed 112 enrolled Yonsei University
RandomizedParallel-groupSingle-blindSupportive care

Summary

Propofol is one of the most commonly used sedative in endoscopic procedures, while its potency to induce respiratory depression may threaten patient safety. Remimazolam is known to less likely induce hemodynamic instability when compared to propofol, yet its favorable effects are not clearly evaluated in endoscopic procedures. Hence, this study aimed to compare hemodynamic effects of remimazolam and propofol, by evaluating oxygen reserve index (ORI) in patients scheduled for endoscopic retrograde cholangiopancreatography.

Timeline

Start
2024-04-11
Primary completion
2024-08-29
Completion
2024-08-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 1 mg/kg
Subject Remimazolam Small molecule 0.1 mg/kg